Comparison of several model-based methods for analysing incomplete quality of life data in cancer clinical trials

Statistics in Medicine

Volumn 17, Issue 5-7, 1998, Pages 781-796

  Fairclough, Diane L ^a   Peterson, Harriet F ^b   Cella, David ^c   Bonomi, Phil ^c  

^a UNIVERSITY OF COLORADO   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; PACLITAXEL; TAMOXIFEN;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER SURVIVAL; CANCER THERAPY; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL;

EID: 2642682430     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0258(19980315/15)17:5/7<781::aid-sim821>3.0.co;2-o     Document Type: Conference Paper

References (16)

1. Little, R. J. A. 'Modeling the drop-out mechanism in repeated-measures studies', Journal of the American Statistical Association, 90, 1112-1121 (1995).
2. SAS Institute Inc. SAS Technical Report P-229. SAS/STAT Software: Changes and Enhancements, Release 6.07, SAS Institute Inc, Cary NC, 1992.
3. Schluchter, M. D. '5V: Unbalanced repeated measures models with structured covariance matrices', in Dixon, W. J. (ed.), BMDP Statistical Software Manual, 2, University of California Press, Berkeley CA, 1990, pp. 1207-1244, 1322-1327.
4. Schluchter, M. D. 'Methods for the analysis of informatively censored longitudinal data', Statistics in Medicine, 11, 1861-1870 (1992).
5. Dempster, A. P., Laird, N. M. and Rubin, D. B. 'Maximum likelihood estimation from incomplete data via the EM algorithm (with discussion)', Journal of the Royal Statistical Society, Series B, 39, 1-38 (1977).
6. Little, R. J. and Rubin, D. B. Statistical Analysis with Missing Data, Wiley, New York, 1987.
7. Troxel, A. B., Fairclough, D. L., Curren, D. and Hahn, E. A. 'Statistical analysis of quality of life with missing data in cancer clinical trials', Statistics in Medicine, 17, 653-666 (1998).
8. DeGruttola, V. and Tu, X. M. 'Modeling progression of CD-4 lymphocyte count and its relationship to survival time', Biometrics, 50, 1003-1014 (1994).
9. Hurny, C., Bernhard, J., Coates, A. S., Castiglione-Gertsch, M., Peterson, H. F., Gelber, R. D., Forbes, J. F., Rudenstam, C. M., Simoncini, E., Crivellari, D., Goldhirsch, A. and Senn, H. J. 'Impact of adjuvant therapy on quality of life in node-positive patients with operable breast cancer', Lancet, 347, 1279-1284 (1996).
10. Hurny, C., Bernhard, J., Bacchi, M., van Wegberg, B., Tomamichel, M., Spek, U., Coates, A., Castiglione, M., Goldhirsch, A. and Senn, H. J. 'The Perceived Adjustment to Chronic Illness Scale (PACIS): A global indicator of coping for operable breast cancer patients in clinical trials', Supportive Care in Cancer, 1, 200-208 (1993).
11. Cella, D. F., Bonomi, A. E., Lloyd, S. R., Tulsky, D. S., Kaplan, E. and Bonomi, P. 'Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument', Lung Cancer, 12, 199-220 (1995).
12. Jennrich, R. and Schluchter, M. 'Unbalanced repeated-measures models with structured covariance matrices', Biometrics, 42, 805-820 (1986).
13. Fairclough, D. L. 'Summary measures and statistics for comparison of quality of life in a clinical trial of cancer therapy', Statistics in Medicine, 17, (1998).
14. Bernhard, J., Peterson, H. F., Coates, A. S., Gusset, H., Isley, M., Hinkle, R., Gelber, R. D., Castiglione-Gertsch, M. and Hürny, C., for the International Breast Cancer Study Group (IBCSG). 'Quality of life assessment in International Breast Cancer Study Group (IBCSG) trials: practical issues and factors associated with missing data', Statistics in Medicine, 17, 587-601 (1998).
15. Fairclough, D. L., Peterson, H. F. and Chang, V. 'Why are missing quality of life data a problem in clinical trials of cancer therapy?', Statistics in Medicine, 17, 667-677 (1998).
16. Zeger, S. L. and Liang, K-Y. 'An overview of methods for the analysis of longitudinal data', Statistics in Medicine, 11, 1825-1839 (1992).